Buying guide
Lingo vs Garmin (Venu / Fenix / Forerunner) in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Abbott | Garmin |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $54 (actual sale price) | $449-$1,699 (actual sale price) |
| Capability claims | — |
|
| Brain | — | — |
| Verified deployments | 1Abbott | 1Garmin |
| Privacy practices | 4third-party-sharing, data-deletion-control, biometric-storage, training-data-use | 5location-tracking, third-party-sharing, data-retention, data-deletion-control, cloud-upload |
| Sources on file | 8 | 18 |
Editorial summaries
Lingo
Abbott's Lingo is an over-the-counter continuous glucose monitor for non-diabetic and wellness consumers, built on Abbott's FreeStyle Libre sensor platform (FDA 510(k) K233655, decided May 29, 2024; Class II integrated CGM): a disposable biosensor worn up to 14 days on the back of the upper arm. It is the adaptive-algorithmic end of the glucose cell, the documented contrast to Stelo's generative AI: the app's 'Lingo Count' daily glucose-spike metric with adaptive targets, food and activity logging, and rule-based personalized recommendations are adaptive-algorithmic, not generative. 'Lingo Live' is free roughly 30-minute sessions with human Abbott nutritionists, not an AI coach, and DEPLOY surfaces that distinction prominently. Pricing starts at about $54 for a 2-week single-biosensor plan, with recurring biweekly and monthly multi-sensor tiers. From Abbott (NYSE: ABT). Cap-flag: the cleared indication is adults 18+ not on insulin, explicitly NOT for diagnosis of any disease including diabetes.
Garmin (Venu / Fenix / Forerunner)
Garmin (the Venu 3 as the biometric-primary anchor at about $449; the Fenix 8 and Forerunner 965 are more athletics-primary and pricier) is the lightest-cleared-portfolio entry in the biometric cohort. Its sensors (Elevate optical heart rate, Pulse Ox/SpO2, ECG on select models, skin temperature) drive Body Battery, Training Load and Training Readiness, advanced sleep and a sleep coach, all-day stress and HRV Status, and a Morning Report. The verified-vs-claimed distinction matters here: only the ECG is FDA-cleared (a 510(k) in 2023, on select models); Body Battery, recovery, and the broader readiness metrics are wellness-grade, and Pulse Ox is not FDA-cleared. Garmin is purchase-only (founded 1989); the optional Garmin Connect+ AI subscription ($6.99/month, March 2025) does not gate any existing features. DEPLOY cap-flags any reading of Garmin's wellness metrics as cleared diagnostics; only the ECG carries a clearance.
Machine-readable: this page as markdown.